Corrigendum to “Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up”: [Annals of Oncology 31 (2020) 17–29, (S0923753419354651), (10.1016/j.annonc.2019.10.010)]

The authors regret that in the section EMZL the sentence “In addition to routine histology and IHC, fluorescent in situ hybridisation (FISH) studies for detection of t(11;18)(p21;p21) may be useful for identifying gastric MZL patients who are unlikely to respond to antibiotic therapy [III, B].5” should read “In addition to routine histology and IHC, fluorescent in situ hybridisation (FISH) studies for detection of t(11;18)(q21;q21) may be useful for identifying gastric MZL patients who are unlikely to respond to antibiotic therapy [III, B].5” The authors would like to apologise for any inconvenience caused.